Published: 2017-04-26

A study of the clinical profile of 50 patients of COPD with correlation between clinical, radiological and spirometric evaluation

Deepali J. Kamdar, Dharmesh Kumar Patel


Background: Chronic obstructive pulmonary disease (COPD) is a common, preventable and treatable disease that is characterised by persistent respiratory symptoms and airflow limitation that is due to airway and/ or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. Tobacco smoking, occupational exposure to organic and inorganic dusts, chemical agents and fumes and biomass cooking are the risk factors for COPD. Chronic dyspnoea, cough, sputum production, wheezing and chest tightness are the common symptoms of COPD. The present study was undertaken to evaluate the clinical, radiological and spirometric parameters in patients with COPD and to demonstrate a correlation between them.

Methods: This was a prospective study of 50 patients of COPD who presented to out- patient department. We included all patients above 40 years of age with a smoking index of 200 or more, or history of exposure to occupational dust, biomass fuel gas or exposure to other obnoxious gases; and who had history of dyspnoea and cough. Spirometry was performed to confirm the diagnosis and to grade the severity of airflow obstruction. History of dyspnoea, cough, sputum production, wheezing, chest tightness, fever, weight loss and the number of exacerbations in the previous year was noted. We then performed a detailed clinical examination. Blood was sent for haemogram and arterial blood gas analysis and all patients underwent an ECG, 2- D Echo and HRCT of the thorax. We then studied the correlation between the clinical, radiological and spirometric profiles in these patients.

Results: Out of the 50 patients, majority was between 50-59 years of age, with male to female ratio of 1.94:1.00. History of smoking was present in 74% patients, exposure to biomass fuel in 12% and exposure to occupational dust in 6% patients. Commonest symptom was dyspnoea (in 100% patients) followed by cough (88%), sputum production (68%), wheezing (58%), chest tightness and fever (30%) and weight loss (28%). HRCT was positive in 75% patients, while ECG changes were seen in 42% patients and pulmonary hypertension was present in 54% patients. A significant association was observed between grade 5 dyspnoea on mMRC, hypoxia, hypercarbia, pulmonary hypertension and Gold-5 airflow obstruction.

Conclusions: In the present study of 50 cases, COPD was seen predominantly in male patients, with a mean age of presentation between 50- 59 years. Tobacco smoking was the commonest etiological factor. Clinical symptoms most commonly documented were dyspnoea, cough with or without expectoration, wheezing, chest tightness, fever and weight loss. A significant association was observed between grade 5 dyspnoea on mMRC, hypoxia, hypercarbia, pulmonary hypertension and Gold-5 airflow obstruction.


Airflow obstruction, Dyspnoea, Hypoxia, Hypercarbia, Pulmonary hypertension, Risk factors

Full Text:



Global initiative for chronic obstructive lung disease: global strategy for the diagnosis, management and prevention of chronic obstructive disease, Report; 2017.

Woodruff PG, Barr RG, Bleecker E. Clinical Significance of symptoms in smokers with preserved pulmonary function. N Engl J Med. 2016;374(19):1811-21.

Regan EA, Lynch DA, Curran- Everett D. Clinical and radiological disease in smokers with normal spirometry. JAMA Intern Med. 2015;175(9):1539-49.

Kohansal R, Martinez- Camblor P, Agusti A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3-10.

Eisner MD, Anthonisen N, Coultas T. An official american thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693-718.

Paulin LM, Diette GB, Blanc PD. Occupational exposures are associated with worse morbidity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(5):557-65.

Assad NA, Balmes J, Mehta S, Cheema U, Sood A. Chronic obstructive pulmonary disease secondary to household air pollution. Semin Resp Crit Care Med. 2015;36(3):408-21.

Miravitlles M, Worth H, Soler Cataluna JJ. Observational study to characterize 24 hour COPD symptoms and their relationship with patient- reported outcomes: result from the ASSESS study. Respir Res. 2014;15:122.

Fletcher CM. Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the aetiology of chronic bronchitis (MRC breathlessness score). BMJ. 1960;2:1662.

Sundh J, Janson C, Lisspers K, Stallberg B, Montgomery S. The dyspnoea, obstruction, smoking, exacerbation (DOSE) index is predictive of mortality in COPD. Prim Care Respir J. 2012;21(3):295-301.

Cho SH, Lin HC, Ghoshal AG. Respiratory disease in Asia- Pacific region: cough as the key symptom. Allergy Asthma Proc. 2016;37(2):131-40.

Von Haehling S, Anker SD. Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle. 2010;1(1):1-5.

Cassart M, Gevenois PA, Estenne M. Rib cage dimensions in hyperinflated patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996;154 (3 Pt 1)800-5.

Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Series ATS/ERS task force: standardisation of lung function testing. Eur Respir J. 2005;26:319-38.

Gupta PP, Yadav R, Verma M, Agrawal D, Kumar M. Correlation between HRCT and patient characteristics in COPD. Annals Thorac Med. 2008;3(3):5-6.

Jain NK, Thakkar MS, Jain N, Rohan KA, Sharma M. Chronic obstructive pulmonary disease. Does gender really matter? Lung India. 2011;28(4):258-62.

Hnizdo E, Sullivan PA, Bang KM, Wagner G. Association between chronic obstructive pulmonary disease and employment by industry and occupation in the US population: a study of data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2002;156(8):738-46.

Ezzati M. Indoor air pollution and health in developing countries. Lancet. 2005;366(9480):104-6.

Birring SS, Brightling CE, Bradding P, Entwisle JJ, Vara DD, Grigg J, et al. Clinical, radiologic and induced sputum features of chronic obstructive pulmonary disease in non- smokers. A descriptive study. Am J Respir Crit Care Med. 2002;166:1078-83.

Niranjan MR, Jayasheelan MR, Rashmi BK. A correlative study of spirometric parameters and ECG changes in patients with chronic obstructive pulmonary disease. Int J Biol Med Res. 2012;3(1):1322-6.

Chabra SK, Gupta AK, Khuma MZ. Evaluation of three scales of dyspnoea in chronic obstructive pulmonary disease. Ann Thorax Med. 2002;4(3):128-32.

Gupta NK, Agrawal RK, Shrivastav AB, Ved ML. Echocardiography evaluation of heart in chronic obstructive pulmonary disease patients and its correlation with severity of disease. Lung India. 2011;28(2):105-9.